RM1-hPSMA

Export PDF

Strain Information

Cell Line

RM1-Tg(hPSMA)Smoc

Cat. NO.

NM-QL01-TM1

Model Description

PSMA gene humanized RM1 cell line

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Fig1. Detection of hPSMA expression in RM1-hPSMA cells in vitro .

image.png

Fig2. In vivo tumor growth curves of RM1-hPSMA cells in hPSMA mice.

Het male hPSMA mice were inoculated with RM1-hPSMA subcutaneously at 2×106 cells/mouse inoculum for tumor development.

image.png

Fig3. Detection of hPSMA expression on tumor cells in subcutaneous xenograft model of RM1-hPSMA cells (The tumors were collected at day 15 post tumor cell inoculation).

Related Strain(s)

CT26-hPSMA (2)
Cell Line：

CT26-Tg(hPSMA)Smoc

Cat. NO.：NM-S24A-TM41
4T1-hPSMA
Cell Line：

4T1-Tg(hPSMA)Smoc

Cat. NO.：NM-S07-TM05
MC38-hPSMA (2)
Cell Line：

MC38-Tg(hPSMA)Smoc

Cat. NO.：NM-S13-TM91
CT26-hPSMA
Cell Line：

CT26-Tg(hPSMA)Smoc

Cat. NO.：NM-S24A-TM07

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more